Speed and trajectory of changes of insomnia symptoms during acute treatment with cognitive-behavioral therapy, singly and combined with medication

Sleep Medicine

Volumn 15, Issue 6, 2014, Pages 701-707

  Morin, Charles M ^a,b   Beaulieu Bonneau, Simon ^a,b   Ivers, Hans ^a,b,c   Vallières, Annie ^a,b,c   Guay, Bernard ^b   Savard, Josée ^a,c   Mérette, Chantal ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Cognitive behavioral therapy; Combined therapy; Insomnia; Medication; Sleep; Treatment response

Indexed keywords

ZOLPIDEM; HYPNOTIC SEDATIVE AGENT; PYRIDINE DERIVATIVE;

ADULT; AGED; ARTICLE; COGNITIVE THERAPY; CONVALESCENCE; CORRELATIONAL STUDY; EVENING DOSAGE; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SLEEP PATTERN; SLEEP QUALITY; SLEEP TIME; SLEEP WAKING CYCLE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; CONTROLLED STUDY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; SLEEP INITIATION AND MAINTENANCE DISORDERS; TIME;

ADULT; AGED; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PYRIDINES; SEVERITY OF ILLNESS INDEX; SLEEP INITIATION AND MAINTENANCE DISORDERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84901606503     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2014.02.004     Document Type: Article

References (34)

1. Morin C.M., Benca R. Chronic insomnia. Lancet 2012, 379:1129-1141.
2. Ohayon M.M. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002, 6:97-111.
3. Roth T., Coulouvrat C., Hajak G., Lakoma M.D., Sampson N.A., Shahly V., et al. Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition criteria: results from the America Insomnia Survey. Biol Psychiatry 2011, 69:592-600.
4. Morin C.M., Jarrin D.C. Epidemiology of insomnia: prevalence, course, risk factors, and public health burden. Sleep Med Clin 2013, 8:281-297.
5. Krystal A.D. A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: the empirical basis for U.S. clinical practice. Sleep Med Rev 2009, 13:265-274.
6. Morin C.M., Bootzin R.R., Buysse D.J., Edinger J.D., Espie C.A., Lichstein K.L. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004). Sleep 2006, 29:1398-1414.
7. National Institutes of Health National Institutes of Health State of the science conference statement on manifestations and management of chronic insomnia in adults, June 13-15, 2005. Sleep 2005, 28:1049-1057.
8. Buysse D.J. Insomnia. JAMA 2013, 309:706-716.
9. Jacobs G.D., Pace-Schott E.F., Stickgold R., Otto M.W. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med 2004, 164:1888-1896.
10. Morin C.M., Colecchi C., Stone J., Sood R., Brink D. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 1999, 281:991-999.
11. Wu R., Bao J., Zhang C., Deng J., Long C. Comparison of sleep condition and sleep-related psychological activity after cognitive-behavior and pharmacological therapy for chronic insomnia. Psychother Psychosom 2006, 75:220-228.
12. Sivertsen B., Omvik S., Pallesen S., Bjorvatn B., Havik O.E., Kvale G., et al. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. JAMA 2006, 295:2851-2858.
13. McClusky H.Y., Milby J.B., Switzer P.K., Williams V., Wooten V. Efficacy of behavioral versus triazolam treatment in persistent sleep-onset insomnia. Am J Psychiatry 1991, 148:121-126.
14. Morin C.M., Vallières A., Guay B., Ivers H., Savard J., Merette C., et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA 2009, 301:2005-2015.
15. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Washington, DC. 4th ed., text revision ed.
16. American Academy of Sleep Medicine The international classification of sleep disorders 2005, American Academy of Sleep Medicine, Westchester, IL. 2nd ed.
17. Buysse D.J., Ancoli-Israel S., Edinger J.D., Lichstein K.L., Morin C.M. Recommendations for a standard research assessment of insomnia. Sleep 2006, 29:1155-1173.
18. Morin C.M. Insomnia: psychological assessment and management 1993, Guilford, New York.
19. Morin C.M., Belleville G., Belanger L., Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep 2011, 34:601-608.
20. Morin C.M., Espie C.A. Insomnia: a clinical guide to assessment and treatment 2003, Kluwer Academic/Plenum, New York.
21. Spielman A.J., Saskin P., Thorpy M.J. Treatment of chronic insomnia by restriction of time in bed. Sleep 1987, 10:45-56.
22. Bootzin R.R., Epstein D., Wood J.M. Stimulus control instructions. Case studies in insomnia 1991, 19-28. Plenum, New York. P.J. Hauri (Ed.).
23. Buysse D.J. Chronic insomnia. Am J Psychiatry 2008, 165:678-686.
24. Curry D.T., Eisenstein R.D., Walsh J.K. Pharmacologic management of insomnia: past, present, and future. Psychiatr Clin North Am 2006, 29:871-893.
25. Richey S.M., Krystal A.D. Pharmacological advances in the treatment of insomnia. Curr Pharm Des 2011, 17:1471-1475.
26. IBM IBM SPSS statistics, version 19 2010, SPSS Inc., Armonk, NY.
27. SPSS Inc. Linear mixed-effects modeling in SPSS: an introduction to the MIXED procedure (technical report) 2005, SPSS Inc., Chicago.
28. Beaulieu-Bonneau S., Fortier-Brochu E., Vallières A., Morin C.M. The impact of prescribing hypnotic medication on compliance with behavioural treatment for insomnia. Sleep 2008, 31(Suppl.):A225.
29. Vallières A., Morin C.M., Guay B. Sequential combinations of drug and cognitive behavioral therapy for chronic insomnia: an exploratory study. Behav Res Ther 2005, 43:1611-1630.
30. Vallières A., Ivers H., Beaulieu-Bonneau S., Morin C.M. Predictability of sleep in patients with insomnia. Sleep 2011, 34:609-617.
31. Miller C.B., Kyle S.D., Marshall N.S., Espie C.A. Ecological momentary assessment of daytime symptoms during sleep restriction therapy for insomnia. J Sleep Res 2013, 22:266-272.
32. Kyle S.D., Morgan K., Spiegelhalder K., Espie C.A. No pain, no gain: an exploratory within-subjects mixed-methods evaluation of the patient experience of sleep restriction therapy (SRT) for insomnia. Sleep Med 2011, 12:735-747.
33. Perlis M.L., McCall W.V., Krystal A.D., Walsh J.K. Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia. J Clin Psychiatry 2004, 65:1128-1137.
34. Vgontzas A.N., Fernandez-Mendoza J. Insomnia with short sleep duration: nosological, diagnostic, and treatment implications. Sleep Med Clin 2013, 8:309-322.